Insulet (PODD) Capital Expenditures (QoQ) (2010 - 2026)
Powered by 
Analysis
Insulet (PODD) Capital Expenditures (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.74% |
| Mar 31, 2026 | -82.01% |
| Dec 31, 2025 | 427.73% |
| Sep 30, 2025 | 37.63% |
| Jun 30, 2025 | 51.22% |
| Mar 31, 2025 | -77.05% |
| Dec 31, 2024 | 100.75% |
| Sep 30, 2024 | 18.67% |
| Jun 30, 2024 | 1.81% |
| Mar 31, 2024 | -24.57% |
| Dec 31, 2023 | 45.77% |
| Sep 30, 2023 | 28.03% |
| Jun 30, 2023 | 49.52% |
| Mar 31, 2023 | -83.70% |
| Dec 31, 2022 | 107.07% |
| Sep 30, 2022 | 113.01% |
| Jun 30, 2022 | 14.06% |
| Mar 31, 2022 | -59.75% |
| Dec 31, 2021 | 16.48% |
| Sep 30, 2021 | 37.19% |